Pyc Therapeutics Ltd has released a press release.
PYC Therapeutics: Half Yearly Report and Accounts
Filed with ASX ·
6ix hasn’t read this filing yet.
PYC Therapeutics Limited on 6ix
Earlier from PYC Therapeutics
- Retail Offer Booklet
- Completion of Placement and Institutional Entitlement Offer
- PYC Raising up to $653m to Deliver Human Efficacy Data
- PYC Capital Raising Presentation
- Trading Halt
Later from PYC Therapeutics
- PKD Clinical Trial - Approval to Escalate Dosing
- Completion of Retail Entitlement Offer
- ADOA Program - SRC Approve Progression to Multi-Dose Study
- Presentation of Ophthalmology Clinical Trial Data at ARVO
- PKD - Initiation of Multiple Dose Clinical Trial
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics